- Tens of thousands of Indonesians rally over Trump's Jerusalem stance
- Second prototype of China's C919 jet conducts test flight: state TV
- North Korea threat on agenda when South Korean foreign minister visits
- Pentagon study of UFOs revealed
- Australia arrests man accused of trying to sell missile parts for Nort
- How Australia's PM went swimming 50 years ago and vanished forever
- Hundreds come down with stomach illness during Royal Caribbean cruise
- Australian police accuse man of acting as North Korean economic agent
- Hoping to extend maritime reach, China lavishes aid on Pakistan town
- Mudslide in southern Chile kills five, at least 15 missing
- Honduran helicopter crash kills six, including president's sister
- Brazil's Workers Party formalizes support for ex-president Lula
- Foreign minister warns UK cannot become 'vassal state' of EU
- More than half of Britons now want to stay in EU - poll
- An update on winners and losers on the U.S. tax scorecard
- Uber accused of espionage, hacking and bribery in bombshell letter
- Christian Bale and more to salute CNN Heroes
- Destiny 2 Xur Location Guide: Where Is Xur, What Is He Selling? (December 15-18)
- More than half of Britons now want to stay in EU: poll
- Mudslide in southern Chile kills three; 15 others missing
Danish pharma company Alk Abello to invest 1 billion crowns in North America
(Reuters) - Danish pharma company Alk Abello said on Monday it would invest about 1 billion Danish crowns ($159.5 million) over the next three years to develop its North America business and said it expected earnings to be subdued during this period.
Alk Abello, which generates about 20 percent of its revenue in North America, said the expansion plan was expected to boost annual revenue growth rate to 10 percent or more after 2018.
But the company expects 2018 revenue to be slightly below 2017.
Reporting by Boleslaw Lasocki; Editing by Thyagaraju Adinarayan and Edmund Blair
Our Standards:The Thomson Reuters Trust Principles.